Provider QP52-21 Commercial and MHCP Pharmacy Benefit Exclusion for AduhelmTM Read More Program effective Date: Jun 23, 2021
Provider QP53-21 Medical Drug Exclusion List Update – for Euflexxa Read More Program effective Date: Jun 23, 2021
Provider QP2R1-21 Update for New to Market Medical Drugs: Aducanumab, Casimersen, Evinacumab, Idecabtagene Vicleucel, and Pegunigalsidase Alfa Read More Program effective Date: Jun 23, 2021
Provider QP58-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Recorlev® (levoketoconazole) Read More Program effective Date: Jul 13, 2022